ACOR - Acorda down 44% after ugly Q2 August, 02 2019 10:28 AM Acorda Therapeutics Inc. Acorda Therapeutics (ACOR -43.7%) slumps on more than double normal volume after reporting Q2 results after the close yesterday.More news on: Acorda Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...